​

Cidara Therapeutics Ownership | Who Owns Cidara Therapeutics?

OverviewForecastFinancialsChartTranscripts

Cidara Therapeutics Ownership Summary

Cidara Therapeutics is owned by 166.66% institutional investors, 0.89% insiders. Ra capital management is the largest institutional shareholder, holding 21.65% of CDTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.55% of its assets in Cidara Therapeutics shares.

CDTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCidara Therapeutics166.66%0.89%-67.55%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management3.37M21.65%$163.93M
Bain capital life sciences investors2.50M16.08%$121.81M
Point72 asset management1.53M9.83%$74.43M
Vivo capital1.31M8.44%$63.88M
Blackrock funding, inc. /de1.11M7.12%$53.95M
Adage capital partners gp1.10M7.08%$53.58M
Tcg crossover management1.01M6.47%$49.00M
Bvf inc/il786.39K5.06%$38.31M
Vr adviser639.09K4.11%$31.13M
Vestal point capital, lp500.00K3.22%$24.36M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bain capital life sciences investors2.50M15.24%$121.81M
Acuta capital partners179.57K12.21%$8.75M
Vivo capital1.31M6.54%$63.88M
Tcg crossover management1.01M5.60%$49.00M
Ikarian capital464.49K4.35%$22.63M
Stempoint capital lp266.77K4.17%$12.99M
Ra capital management3.37M2.76%$163.93M
Vr adviser639.09K2.33%$31.13M
Sphera funds management138.00K1.58%$6.72M
Soleus capital management462.81K1.49%$22.54M

Top Buyers

HolderShares% AssetsChange
Ra capital management3.37M2.76%2.27M
Bain capital life sciences investors2.50M15.24%1.80M
Point72 asset management1.53M0.15%1.41M
Blackrock funding, inc. /de1.11M0.00%1.05M
Vivo capital1.31M6.54%627.15K

Top Sellers

HolderShares% AssetsChange
Vanguard group---3.35M
Renaissance---2.55M
5am venture management---1.13M
Geode capital management---838.29K
Blackrock---715.41K

New Positions

HolderShares% AssetsChangeValue
Soleus capital management462.81K1.49%462.81K$22.54M
Jefferies financial group450.00K0.18%450.00K$21.92M
Caption management268.00K0.14%268.00K$13.05M
Sofinnova investments251.03K0.75%251.03K$12.23M
Deep track capital, lp250.00K0.39%250.00K$12.18M

Sold Out

HolderChange
Qube research-52.00
Avion wealth-250.00
Cubist systematic strategies-290.00
Bnp paribas arbitrage, snc-353.00
Jpmorgan chase-451.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025121163.04%25,911,048172.67%1663.71%98262.96%7-22.22%
Mar 31, 20254720.51%9,559,38739.46%670.58%27-10.00%9200.00%
Dec 31, 20243944.44%6,854,593107.19%1074.21%30100.00%3-
Sep 30, 202427-3,308,428133.57%505.26%15150.00%--100.00%
Jun 30, 20241-98.04%4,000-99.98%-0.01%--100.00%--100.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv592.28K2.55%-13.13K
iShares Russell 2000 ETF395.57K1.79%-7.56K
Vanguard US Total Market Shares ETF121.55K1.11%-
abrdn Healthcare Investors179.90K0.77%-
Vanguard Institutional Extnd Mkt Idx Tr159.67K0.69%-69.89K
iShares Russell 2000 Value ETF146.91K0.66%109.00
Invesco Dorsey Wright SmallCap Momt ETF105.27K0.48%-
State St Russell Sm/Mid Cp® Indx SL Cl I93.02K0.42%72.02K
Fidelity Extended Market Index79.80K0.36%53.54K
Vanguard Russell 2000 ETF80.09K0.34%-5.56K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 26, 2025RA CAPITAL MANAGEMENT, L.P. Buy$100.00M
Jun 03, 2025Mineo Chrysa-Buy$24.61K
Jun 02, 2025Mineo Chrysa-Buy$49.28K
Mar 11, 2025Ward Shane COO & CLOSell$36.54K
Mar 11, 2025Tari Leslie CHIEF SCIENTIFIC OFFICERSell$38.94K

Insider Transactions Trends

DateBuySell
2025 Q22-
2025 Q1-2
2024 Q4--
2024 Q3-2
2024 Q21-

CDTX Ownership FAQ

Who Owns Cidara Therapeutics?

Cidara Therapeutics shareholders are primarily institutional investors at 166.66%, followed by 0.89% insiders and -67.55% retail investors. The average institutional ownership in Cidara Therapeutics's industry, Biotech Stocks , is 304.14%, which Cidara Therapeutics falls below.

Who owns the most shares of Cidara Therapeutics?

Cidara Therapeutics’s largest shareholders are Ra capital management (3.37M shares, 21.65%), Bain capital life sciences investors (2.5M shares, 16.08%), and Point72 asset management (1.53M shares, 9.83%). Together, they hold 47.56% of Cidara Therapeutics’s total shares outstanding.

Does Blackrock own Cidara Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cidara Therapeutics.

Who is Cidara Therapeutics’s biggest shareholder by percentage of total assets invested?

Bain capital life sciences investors is Cidara Therapeutics’s biggest shareholder by percentage of total assets invested, with 15.24% of its assets in 2.5M Cidara Therapeutics shares, valued at 121.81M$.

Who is the top mutual fund holder of Cidara Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cidara Therapeutics shares, with 2.55% of its total shares outstanding invested in 592.28K Cidara Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools